For instance, the lncRNA plasmacytoma variant translocation 1 (PVT1) activates the Wnt/β-catenin pathway to promote gemcitabine resistance of pancreatic cancer [13]. This evidence concerns the gene PVT1 and pancreatic neoplasm.